ATLASAxsome Therapeutics (AXSM) Q3 2026 earnings results
Axsome Therapeutics (AXSM) reported EPS of -$0.25 against an analyst estimate of -$0.69: a beat of $0.44 (63.8%). The quarter ended Sep 30, 2026; the company reported on Monday, November 2, 2026, before the open.
Status: Confirmed · 17:12 ET, Nov 2 · Source: EODHD (calendar and fundamentals, cross-checked)
Notify me when Axsome Therapeutics reports
Track AXSM free Add Axsome Therapeutics to a free ATLAS watchlist.
AXSM Q3 2026 results at a glance
| EPS reported | -$0.25 |
|---|---|
| EPS estimate | -$0.69 |
| Surprise | Beat · +$0.44 (+63.8%) |
| Quarter ended | Sep 30, 2026 |
| Reported | Nov 2, 2026, before the open |
| Status | Confirmed · 17:12 ET, Nov 2 |
EPS is as supplied by EODHD, in US dollars per share; whether it is adjusted or GAAP follows that source. This is Axsome Therapeutics’s Q3 2026, a calendar-year company.
Axsome Therapeutics EPS surprise history: last 4 quarters
Axsome Therapeutics beat the EPS estimate in 3 of its last 4 reports, with an average surprise of +54.9%.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Nov 2, 2026 | -$0.69 | -$0.25 | +63.8% | Beat | – |
| Aug 10, 2026 | -$0.78 | -$0.99 | -26.9% | Miss | +1.4% |
| May 22, 2026 | $1.34 | $1.78 | +32.8% | Beat | +0.2% |
| Mar 4, 2026 | $0.06 | $0.15 | +150.0% | Beat | -1.6% |
*Move: change in the closing price from the last close before the report day to the close the day after it. It is filled in a few trading days after each report.
AXSM stock reaction to the report
AXSM moved -5.90% in the first session that reflects the report (close of Oct 30, 2026 $144.43 to close of Nov 2, 2026 $135.91).
Next AXSM earnings report
Axsome Therapeutics has not announced its next earnings date yet. This page shows a date only once it is confirmed. See the AXSM earnings calendar.
ATLAS fair value and signal for AXSM
| Last price | $135.91 (-5.9%) |
|---|---|
| Chance of a higher close in 1 month | 49% (normal range $125.41–$146.51) |
These are model outputs from the same valuation and calibrated model as the Axsome Therapeutics stock page. They describe an ordinary period and are not a forecast of any particular outcome.
Axsome Therapeutics Q3 2026 earnings: frequently asked questions
Did Axsome Therapeutics beat earnings estimates for Q3 2026?
Axsome Therapeutics reported EPS of -$0.25 against an analyst estimate of -$0.69: a beat of $0.44 (63.8%).
When did Axsome Therapeutics report Q3 2026 results?
Axsome Therapeutics reported on Monday, November 2, 2026, before the open, for the quarter ended Wednesday, September 30, 2026.
How often does AXSM beat EPS estimates?
In its last 4 reports with a recorded result, Axsome Therapeutics beat the EPS estimate 3 times; the average surprise was +54.9%. Past results do not predict the next one.
How does ATLAS confirm a result?
A result is published only after it is cross-checked: the EODHD earnings calendar and the EODHD fundamentals feed must show the same EPS for the same fiscal period, or the same value must appear in two consecutive checks. Unconfirmed figures are never published. If the figures are revised later, this page updates.
Educational information, not investment advice. Disclaimer